TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Uroderma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
11,859
|
10,085
|
8,875 |
Financial expenses |
15
|
4
|
0 |
Earnings before taxes |
5,585
|
5,163
|
3,655 |
EBITDA |
5,797
|
5,383
|
4,009 |
Total assets |
10,386
|
9,288
|
7,410 |
Current assets |
4,460
|
4,313
|
4,992 |
Current liabilities |
861
|
1,708
|
1,809 |
Equity capital |
9,525
|
7,580
|
5,601 |
- share capital |
51
|
47
|
49 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
91.7%
|
81.6%
|
75.6% |
Turnover per employee |
3,953
|
3,362
|
2,958 |
Profit as a percentage of turnover |
47.1%
|
51.2%
|
41.2% |
Return on assets (ROA) |
53.9%
|
55.6%
|
49.3% |
Current ratio |
518.0%
|
252.5%
|
276.0% |
Return on equity (ROE) |
58.6%
|
68.1%
|
65.3% |
Change turnover |
1,058
|
1,478
|
1,987 |
Change turnover % |
10%
|
17%
|
29% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.